These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 25412857

  • 1. High-risk HPV platforms and test of cure: should specific HPV platforms more suited to screening in a 'test of cure' scenario be recommended?
    Innamaa A, Dudding N, Ellis K, Crossley J, Smith JH, Tidy JA, Palmer JE.
    Cytopathology; 2015 Dec; 26(6):381-7. PubMed ID: 25412857
    [Abstract] [Full Text] [Related]

  • 2. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
    Huijsmans CJ, Geurts-Giele WR, Leeijen C, Hazenberg HL, van Beek J, de Wild C, van der Linden JC, van den Brule AJ.
    BMC Cancer; 2016 Nov 28; 16(1):922. PubMed ID: 27894291
    [Abstract] [Full Text] [Related]

  • 3. Does LLETZ excision margin status predict residual disease in women who have undergone post-treatment cervical cytology and high-risk human papillomavirus testing?
    Palmer JE, Ravenscroft S, Ellis K, Crossley J, Dudding N, Smith JH, Tidy JA.
    Cytopathology; 2016 Jun 28; 27(3):210-7. PubMed ID: 26415635
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the performance of HPV tests in women with abnormal cytology: results of a study within the NHS cervical screening programme.
    Moss SM, Bailey A, Cubie H, Denton K, Sargent A, Muir P, Vipond IB, Winder R, Kitchener H.
    Cytopathology; 2015 Dec 28; 26(6):373-80. PubMed ID: 25274541
    [Abstract] [Full Text] [Related]

  • 5. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.
    Health Technol Assess; 2014 Apr 28; 18(23):1-196. PubMed ID: 24762804
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
    Zhou F, Pulinthanathu R, Elgert P, Cangiarella J, Simsir A.
    Diagn Cytopathol; 2015 May 28; 43(5):381-7. PubMed ID: 25546355
    [Abstract] [Full Text] [Related]

  • 7. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O, Kares S, Kujala P, Tirkkonen M, Vuento R, Kholová I, Luukkaala T, Osuala V, Mäenpää J.
    Acta Obstet Gynecol Scand; 2016 Nov 28; 95(11):1220-1227. PubMed ID: 27591407
    [Abstract] [Full Text] [Related]

  • 8. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
    Rao A, Sandri MT, Sideri M, Young S, Sharma A, Behrens C.
    J Clin Virol; 2013 Sep 28; 58(1):161-7. PubMed ID: 23895930
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.
    Cook DA, Mei W, Smith LW, van Niekerk DJ, Ceballos K, Franco EL, Coldman AJ, Ogilvie GS, Krajden M.
    BMC Cancer; 2015 Dec 16; 15():968. PubMed ID: 26674353
    [Abstract] [Full Text] [Related]

  • 13. Risk of cervical high-grade squamous intraepithelial neoplasia in cytologic negative and persistently high-risk human papillomavirus positive patients according to genotypes: a retrospective single center analysis.
    Kipp B, Ulrich E, van Meegen C, Schwenzer T.
    BMC Infect Dis; 2024 Jun 04; 24(1):558. PubMed ID: 38834951
    [Abstract] [Full Text] [Related]

  • 14. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
    Luyten A, Scherbring S, Reinecke-Lüthge A, Braun BE, Pietralla M, Theiler K, Petry KU.
    J Clin Virol; 2009 Nov 04; 46 Suppl 3():S5-10. PubMed ID: 20129072
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the Clinical Performance of Aptima HPV Assay and the Cobas 4800 Platform in Women with Normal Cytology and Positive High-Risk HPV.
    Kir G, Dokmeci Guney D, Seneldir H.
    Acta Cytol; 2023 Nov 04; 67(4):395-402. PubMed ID: 36977394
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.